Esculetin induces cell cycle arrest and apoptosis in human colon cancer LoVo cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Yong J. | - |
dc.contributor.author | Lee, Chang M. | - |
dc.contributor.author | Park, See-Hyoung | - |
dc.contributor.author | Nam, Myeong J. | - |
dc.date.available | 2020-07-10T02:38:51Z | - |
dc.date.created | 2020-07-06 | - |
dc.date.issued | 2019-10 | - |
dc.identifier.issn | 1520-4081 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hongik/handle/2020.sw.hongik/1082 | - |
dc.description.abstract | We investigated the anti-cancer effects of ESC in human colon cancer LoVo cells. Cell counting assay results showed that ESC inhibited the proliferation of LoVo cells. Cell cycle arrest results showed that cell cycle was arrested during the G0/G1 phase in the ESC-treated LoVo cells. Western blot results showed that the cell cycle inhibitory proteins p53, p27, and p21 were increased, and cyclin D1, the cell cycle progressive protein, was decreased. Sp1 is a transcription factor regulating cell proliferation, was decreased in the ESC-treated LoVo cells. Annexin V/propidium iodide staining results showed that ESC induces apoptosis in LoVo cells. Western blot results showed that Bax, cleaved caspase -3, -7, -9, and poly(ADP-ribose) polymerase, which are proapoptotic proteins, were increased and the antiapoptotic protein Bcl-2 was decreased. Taken together, ESC induced apoptosis and has an anti-cancer effect in LoVo cells. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.subject | TRANSCRIPTION FACTOR SP1 | - |
dc.subject | ORAL SQUAMOUS CANCER | - |
dc.subject | COLORECTAL-CANCER | - |
dc.subject | UP-REGULATION | - |
dc.subject | EXPRESSION | - |
dc.subject | INHIBITOR | - |
dc.subject | COUMARIN | - |
dc.subject | INDUCTION | - |
dc.subject | ANTITUMOR | - |
dc.subject | CURCUMIN | - |
dc.title | Esculetin induces cell cycle arrest and apoptosis in human colon cancer LoVo cells | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, See-Hyoung | - |
dc.identifier.doi | 10.1002/tox.22815 | - |
dc.identifier.scopusid | 2-s2.0-85069717620 | - |
dc.identifier.wosid | 000476065800001 | - |
dc.identifier.bibliographicCitation | ENVIRONMENTAL TOXICOLOGY, v.34, no.10, pp.1129 - 1136 | - |
dc.relation.isPartOf | ENVIRONMENTAL TOXICOLOGY | - |
dc.citation.title | ENVIRONMENTAL TOXICOLOGY | - |
dc.citation.volume | 34 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 1129 | - |
dc.citation.endPage | 1136 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Environmental Sciences & Ecology | - |
dc.relation.journalResearchArea | Toxicology | - |
dc.relation.journalResearchArea | Water Resources | - |
dc.relation.journalWebOfScienceCategory | Environmental Sciences | - |
dc.relation.journalWebOfScienceCategory | Toxicology | - |
dc.relation.journalWebOfScienceCategory | Water Resources | - |
dc.subject.keywordPlus | TRANSCRIPTION FACTOR SP1 | - |
dc.subject.keywordPlus | ORAL SQUAMOUS CANCER | - |
dc.subject.keywordPlus | COLORECTAL-CANCER | - |
dc.subject.keywordPlus | UP-REGULATION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | INHIBITOR | - |
dc.subject.keywordPlus | COUMARIN | - |
dc.subject.keywordPlus | INDUCTION | - |
dc.subject.keywordPlus | ANTITUMOR | - |
dc.subject.keywordPlus | CURCUMIN | - |
dc.subject.keywordAuthor | apoptosis | - |
dc.subject.keywordAuthor | cell cycle | - |
dc.subject.keywordAuthor | colon cancer cell | - |
dc.subject.keywordAuthor | esculetin | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
94, Wausan-ro, Mapo-gu, Seoul, 04066, Korea02-320-1314
COPYRIGHT 2020 HONGIK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.